IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vida Ventures Advisors, LLC

Q4 2021 Holdings

Filed 2022-02-10 | 8 holdings | $27.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Allogene Therapeutics, Inc.(ALLO)Common Stock019770106$26.8M1,798,16399.1%
Praxis Precision Medicines, Inc.Common Stock74006W108$57.9K2,939,3290.2%
Kinnate Biopharma, Inc.Common Stock49705R105$48.7K2,747,4330.2%
Centessa Pharmaceuticals plc(CNTA)Ordinary Shares152309100$44.3K3,931,8180.2%
Kronos Bio, Inc.(KRON1USD)Common Stock50107A104$37.6K2,765,3140.1%
Dyne Therapeutics, Inc.(DYN)Common Stock26818M108$35.2K2,960,0460.1%
LianBioOrdinary Shares53000N108$14.1K2,282,0840.1%
Homology Medicines, Inc.Common Stock438083107$2.8K770,8450.0%